FDA approved AstraZeneca’s Brilinta to reduce the risk of stroke
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability ...
ADVERTISEMENT
